Reduced expression and prognostic implication of inhibitor of growth 4 in human osteosarcoma

Dahang Zhao1, Xiangjie Liu1, Yunge Zhang1

  • 1The Third Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China.

Oncology Letters
|April 14, 2016
PubMed

Insights

Inhibitor of growth 4 (ING4) shows reduced expression in osteosarcoma, a common bone cancer. This low ING4 expression correlates with advanced tumor classification, suggesting ING4 as a potential prognostic marker for osteosarcoma.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • Osteosarcoma is the most common primary malignant bone tumor.
  • Inhibitor of growth 4 (ING4) acts as a tumor suppressor and its expression is reduced in many cancers.
  • Understanding ING4's role in osteosarcoma is crucial for developing new diagnostic and therapeutic strategies.

Purpose of the Study:

  • To investigate the expression levels of ING4 in osteosarcoma tissues.
  • To evaluate the prognostic value of ING4 expression in osteosarcoma.
  • To determine the correlation between ING4 expression and tumor classification.

Main Methods:

  • Analysis of formalin-fixed, paraffin-embedded tissue microarrays from 41 osteosarcoma and 11 normal bone specimens.
  • Immunohistochemical staining to evaluate ING4 expression.
  • Statistical analysis to compare ING4 expression between tumor and normal tissues and correlate with Enneking classification.

Main Results:

  • Significantly lower ING4 expression was observed in osteosarcoma tissues compared to normal bone tissues (P<0.001).
  • A significant negative correlation was found between ING4 expression levels and Enneking classification of osteosarcoma (P=0.002).
  • Low ING4 expression was associated with more advanced stages of osteosarcoma.

Conclusions:

  • ING4 expression is significantly reduced in osteosarcoma.
  • Reduced ING4 expression is negatively correlated with tumor stage in osteosarcoma.
  • ING4 may serve as a valuable prognostic biomarker for osteosarcoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K